GUARDION HEALTH SCIENCES INC (GHSI)
US40145Q5009 - Common Stock
Guardion Health Sciences Announces Declaration of Cash Distribution
HOUSTON, TEXAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) today announced that its Board of...
Guardion Health Sciences Announces Filing of Certificate of Dissolution
HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that it has...
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that its...
GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q2 2024
GHSI stock results show that Guardion Health Sciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Guardion Health Sciences (NASDAQ:GHSI) just reported results for the second qua...
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
Guardion Also Provides an Update to Stockholders of Significant Recent Developments HOUSTON, TEXAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Guardion Health...
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition...
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
Adjourns Special Meeting to May 31, 2024 in order to Solicit Additional Proxies in Support of its Plan of Liquidation and Dissolution HOUSTON, TEXAS,...
GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024
GHSI stock results show that Guardion Health Sciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Guardion Health Sciences (NASDAQ:GHSI) just reported results for the first quar...
Guardion Health Sciences Announces
-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as...
Why Is Guardion Health (GHSI) Stock Up 66% Today?
Guardion Health Sciences stock is rising higher on Wednesday as investors in GHSI react to it selling its Viactiv brand and business.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest ones worth keeping an eye on this morning!
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
Viactiv® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended...
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023
Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022;...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer
Former President and Chief Executive Officer Bret Scholtes Resigning to Pursue Other Business Opportunities...
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023
Viactiv® Product Line Total Revenue Increased approximately 37% for the Quarter Ended March 31, 2023 as compared to the Quarter Ended March 31, 2022...
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022
Viactiv® Product Line Generated Net Revenues of approximately $10.6 Million or 96% of Net Revenues for the Year Ended December 31, 2022...
Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has...
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will...